Colitis ulcerosa: vizsgálatok itt: Németország
32 of 39 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Where
- Berlin, Brandenburg An Der Havel, Bremen, Dachau, Frankfurt Am Main, Kiel, Leipzig, Munich, Tuebingen, Ulm
- Életkor
- 18 év to 75 év
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00 - 1. fázisBefejeződöttAn Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
- Where
- Berlin
- Életkor
- 18 év to 60 év
- People
- 25 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07665723 · EU 2025-524060-38-00 - 3. fázisTaking peopleA study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis
- Where
- Aachen, Leipzig, Mainz, Tuebingen
- Életkor
- Up to 17 év
- People
- 68 worldwide
- Run by
- Alfasigma S.p.A.
See details and how to join2024-511458-32-00 - 2. fázisTaking peopleA Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- Where
- Brandenburg An Der Havel, Rostock, Ulm
- Életkor
- 18 év to 75 év
- People
- 100 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07463183 · EU 2025-523479-49-00 - 2. fázisFut, nem toborozAn Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
- Where
- Augsburg, Berlin, Brandenburg An Der Havel, Duisburg, Frankfurt Am Main, Halle (Saale), Hamburg, Hanover, Kiel, Munich, Remscheid, Ulm
- Életkor
- 18 év and over
- People
- 587 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2023-507853-13-00 - 2. fázisNot yet taking people in NémetországLong-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
- Where
- Berlin, Brandenburg An Der Havel, Bremen, Dachau, Frankfurt Am Main, Kiel, Leipzig, Munich, Tuebingen, Ulm
- Életkor
- 18 év and over
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00 - 1. fázisTaking peopleAn Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 Substrates
- Where
- Berlin, Cottbus, Munich, Ulm
- Életkor
- 18 év to 65 év
- People
- 25
- Run by
- Sanofi
See details and how to joinNCT07923383 · EU 2026-525939-17-00 - 3. fázisTaking peopleMirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Frankfurt, Grevenbroich, Halle, Hanover, Leipzig, Potsdam
- Életkor
- 18 év to 70 év
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00 - 2. fázisTaking peopleLY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Where
- Berlin, Dachau, Erlangen, Regensburg, Ulm
- Életkor
- 18 év to 80 év
- People
- 252 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07186101 - 2. fázisTaking peopleA Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Where
- Berlin, Dachau, Halle (Saale), Ludwigshafen am Rhein, Ulm
- Életkor
- 18 év to 80 év
- People
- 60 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07483073 · EU 2025-524112-11-00 - 3. fázisTaking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Hamburg, Sankt Augustin
- Életkor
- 3 év to 64 év
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - 3. fázisTaking peopleA Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Berlin, Dachau, Dresden, Erlangen, Frankfurt Am Main, Halle (Saale), Halle Saale, Hanover, Jena, Kassel, Kiel, Leipzig, Mannheim, Munich, Regensburg, Rostock, Ulm
- Életkor
- 18 év and over
- People
- 644 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00 - 4. fázisTaking peopleA study to measure mirikizumab levels in breast milk of lactating participants receiving mirikizumab therapeutically for an approved indication
- Where
- Frankfurt
- People
- 16 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2025-522362-78-00 - 2. fázisTaking peopleA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Where
- Frankfurt Am Main, Regensburg
- Életkor
- 18 év and over
- People
- 224 worldwide
- Run by
- Genentech, Inc.
See details and how to joinNCT06979336 · EU 2025-520690-39-00 - 3. fázisTaking peopleA Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Where
- Cottbus, Erlangen, Kassel, Muenster, Potsdam
- Életkor
- 2 év to 17 év
- People
- 120 worldwide
- Run by
- AbbVie
See details and how to joinNCT07071519 · EU 2024-514695-41-00 - 2. fázisNot yet taking people in NémetországStudy of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Where
- Berlin, Dachau, Frankfurt Am Main, Freiburg im Breisgau, Halle (Saale), Hamburg, Hanover, Jerichow, Kiel, Leipzig, Ludwigshafen am Rhein, Luebeck, Lueneburg, Magdeburg, Mannheim, Pforzheim, Potsdam, Rostock, Ulm
- Életkor
- 18 év to 75 év
- People
- 2000 worldwide
- Run by
- AbbVie
See details and how to joinNCT07697456 · EU 2026-525959-86-00 - 2. fázisTaking peopleA Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
- Where
- Leipzig, Muenster, Tuebingen, Wuppertal
- Életkor
- 2 év to 11 év
- People
- 24 worldwide
- Run by
- Pfizer
See details and how to joinNCT07470879 · EU 2025-523100-77-00 - 3. fázisTaking peopleAn Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Berlin, Halle, Herne, Kiel, Leipzig, Minden, Ulm, Wolfsburg
- Életkor
- 16 év to 80 év
- People
- 980 worldwide
- Run by
- Sanofi
See details and how to joinNCT07184996 - 2/3. fázisTaking peopleEfficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients With Mild to Moderately Active Ulcerative Colitis
- Where
- Aachen, Augsburg, Bamberg, Berlin, Bremen, Cologne, Darmstadt, Dornstadt, Dresden, Frankfurt am Main, Frankfurt Am Main, Halle (Saale), Hamburg, Hamm, Hannover, Heidelberg, Kiel, Ludwigshafen am Rhein, Luebeck, Magdeburg, Mannheim, Muenster, Ulm
- Életkor
- 18 év to 80 év
- People
- 459
- Run by
- University Hospital Schleswig-Holstein
See details and how to joinNCT06488625 · EU 2024-510807-13-00 - 2/3. fázisTaking peopleA Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Where
- Dresden, Leipzig, München
- Életkor
- 2 év to 17 év
- People
- 120 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05076175 - 3. fázisTaking peopleA Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
- Where
- Aachen, Leipzig, Mainz, Tübingen
- Életkor
- 8 év to 18 év
- People
- 80 worldwide
- Run by
- Alfasigma S.p.A.
See details and how to joinNCT06865417 - 3. fázisTaking peopleA Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Berlin, Halle, Kiel, Leipzig, Minden, Tübingen, Ulm
- Életkor
- 16 év to 80 év
- People
- 751 worldwide
- Run by
- Sanofi
See details and how to joinNCT07185009 - 2. fázisTaking peopleLY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study
- Where
- Berlin, Dachau, Erlangen, Regensburg, Ulm
- Életkor
- 18 év and over
- People
- 75 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2025-522338-30-00 - 3. fázisTaking peopleA Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Where
- Mainz, Munich
- Életkor
- 2 év to 19 év
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT04844606 - No phaseTaking peopleWild Blueberries in Colitis
- Where
- Bamberg
- Életkor
- 18 év and over
- People
- 60
- Run by
- Universität Duisburg-Essen
See details and how to joinNCT06698601